January 19, 2023
January 19, 2023 -
Seagen Inc. announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Tukysa
January 17, 2023
FDA Approves Adacel for Immunization During Pregnancy to Help Protect Young
Infants Against Pertussis
January 17, 2023 -
The U.S. Food and Drug Administration (FDA) has approved Adacel (Tetanus Toxoid,
Reduced Diphtheria Toxoid and Acellular Pertussis
January 15, 2023
January 15, 2023 -
Luye Pharma Group (Luye Pharma), an international pharmaceutical company dedicated to the R&D, manufacturing and sale
January 13, 2023
January 13, 2023 –
The FDA signed the Agreement on Mutual Recognition between the Swiss Confederation and the U.S. Relating to Pharmaceutical Good Manufacturing Practice.
January 12, 2023
January 12, 2023 -
The FDA has approved a label update for Rybelsus (semaglutide) tablets 7 mg or 14 mg, allowing use as a first-line treatment option for adults
January 11, 2023
January 11, 2023 -
Airsupra (albuterol/budesonide), formerly known as PT027, has been approved in the
US for the as-needed treatment or prevention
January 6, 2023
January 6, 2023 -
The U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb)
January 3, 2023
Jan. 3, 2023 --
Prophylactic use of methylprednisolone does not reduce the likelihood of a worse
outcome for infants undergoing surgery with cardiopulmonary bypass